Histogenics Proposes $65M IPO )HealthPointCapital)
Histogenics Corporation filed an S-1 to raise up to $65 million through an initial public offering (IPO) of common shares. The price range and number of shares to be sold in the offering has not yet been determined.
Histogenics' principal stockholders Sofinnova Venture Partners, Split Rock Partners and Wilmslow Estates Limited, have indicated an interest in purchasing an aggregate of up to $15 million of common stock through this offering. Furthermore, Intrexon Corporation, which holds a convertible promissory note in the principal amount of $...
The Orthopedics Industry 